南京普济生物有限公司 logo — 德以普济为弘。南京普济生物致力于打造让每位老百姓都用得起的基...

南京普济生物有限公司

德以普济为弘。南京普济生物致力于打造让每位老百姓都用得起的基因检测产品!

Founded 2019 China China 3 employees Angel Total: $100.00M Biotechnology, Health Care +1

General Information

Company Name 南京普济生物有限公司
Founded Year 2019
Location China China
Employees 3
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Angel
Social

BounceWatch is an independent company data service, not affiliated with 南京普济生物有限公司. To contact 南京普济生物有限公司, visit pregene.net.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does 南京普济生物有限公司 compare?

A PDF of 南京普济生物有限公司 and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting 南京普济生物有限公司 soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About 南京普济生物有限公司

Puji Bio is a biotechnology startup that was founded in 2019 in China. The company's slogan, "德以普济为弘。南京普济生物致力于打造让每位老百姓都用得起的基因检测产品!", reflects their commitment to making genetic testing affordable for everyone. Puji Bio's core technology, the ultra-multiplex PCR technology, is patented and enables rapid and cost-effective clinical applications that were previously only achievable on complex platforms. The startup's product portfolio is primarily focused on clinical applications such as tumor diagnosis and treatment (companion diagnostics, prognostic monitoring) and NIPT for screening birth defects. The last recorded investment for Puji Bio was a significant CNY100.00M Angel Round investment on 10 January 2022, with participation from Vertex Ventures China and Season Venture Capital. With its innovative technology and focus on addressing critical healthcare needs, Puji Bio presents an intriguing investment opportunity in the biotechnology sector.

Business keywords: Molecular Diagnostics, Genetic Testing, Tumor Diagnosis, Birth Defect Screening, PCR Technology, Medical Technology, Healthcare Innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Angel Round CNY100.00M 2
Vertex Ventures China, Season Venture Capital
10 Jan 2022

南京普济生物有限公司 Alternatives & Competitors

View All Alternatives
南京普济生物有限公司 vs

LIFE SCIENCE TECHNOLOGY

Corporate Round
3 employees
Biotechnology, Health Care
南京普济生物有限公司 vs

Precision Molecular Diagnostics & Genetic Testing

Seed
15 employees
Biotechnology, Health Care
南京普济生物有限公司 vs
CIAN Diagnostics
CIAN Diagnostics United States

Your Solution for accurate & reliable COVID-19 testing

46 employees
Biotechnology, Health Care

FAQ About 南京普济生物有限公司

德以普济为弘。南京普济生物致力于打造让每位老百姓都用得起的基因检测产品!
南京普济生物有限公司 was founded in 2019.
南京普济生物有限公司 is headquartered in China.
南京普济生物有限公司 operates in Biotechnology, Health Care and Medical Devices. Its work centres on Molecular Diagnostics, Genetic Testing, Tumor Diagnosis and Birth Defect Screening.
南京普济生物有限公司 has approximately 3 employees.
南京普济生物有限公司 has completed 1 funding round, raising a total of $100.00M. The latest funding stage is Angel.
Top alternatives and competitors to 南京普济生物有限公司 include SHENZHEN UNI-MEDICA TECHNOLOGY , Dhiti Omics, CIAN Diagnostics, Suzhou Molarray Co., Ltd., Molbio Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
南京普济生物有限公司 and SHENZHEN UNI-MEDICA TECHNOLOGY are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for 南京普济生物有限公司, https://bouncewatch.com/company/puji-bio, updated 21 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes